AAAAAA

   
Results: 1-13 |
Results: 13

Authors: LAFAY L VRAY M BOUTE D BASDEVANT A
Citation: L. Lafay et al., FOOD AND NUTRITIONAL DATA FOR A POPULATION FROM NORTHERN FRANCE - THEFLEURBAIX-LAVENTIE-VILLE-SANTE (FLVS) STUDY, Revue d'epidemiologie et de sante publique, 46(4), 1998, pp. 263-275

Authors: BUXTON MJ DRUMMOND MF VANHOUT BA PRINCE RL SHELDON TA SZUCS T VRAY M
Citation: Mj. Buxton et al., MODELING IN ECONOMIC-EVALUATION - AN UNAVOIDABLE FACT OF LIFE, Health economics, 6(3), 1997, pp. 217-227

Authors: LAFAY L BASDEVANT A CHARLES MA VRAY M BALKAU B BORYS JM ESCHWEGE E ROMON M
Citation: L. Lafay et al., DETERMINANTS AND NATURE OF DIETARY UNDERREPORTING IN A FREE-LIVING POPULATION - THE FLEURBAIX-LAVENTIE-VILLE-SANTE (FLVS) STUDY, International journal of obesity, 21(7), 1997, pp. 567-573

Authors: BOISSEL JP PERRET L BOUVENOT G CASTAIGNE A GERARDCOUE MJ MAILLERE P MISMETTI P VRAY M AVOUAC B BEGAUD B CAULIN C CHARPAK Y CHAUMETRIFFAUD P COSTAGLIOLA D DEGOS F DESTORS JM DOYON F FAGNANI F GIRI I GIRRE JP GOEHRS JM KHER A MOCCATTI D MUNOZ A DECURZON AP PLETAN Y ROY P VASMANT D WAJMAN A
Citation: Jp. Boissel et al., INTERMEDIATE AND SURROGATE OUTCOMES IN CL INICAL-EVALUATION OF DRUGS, Therapie, 52(4), 1997, pp. 281-285

Authors: VRAY M SCHWARTZ D
Citation: M. Vray et D. Schwartz, COMMENTS ON A PRAGMATIC TRIAL, Journal of clinical epidemiology, 49(8), 1996, pp. 949-949

Authors: CARBON C WARRELL D ABOULKER JP COOPER DA DARBYSHIRE JH DORMONT J FLEPP M LANGE J LEVY JP MATHIESEN L PETO TEA PINCHING AJ REISS P SCHWARTZ D SELIGMANN M STONE A THOMIS J WITHNALL R BARKER S FRISSEN PJ DEJONG MD LOEWENTHAL M TOURNERIE C VALENTINE C ABER V BABIKER AG CHARREAU I THAKRAR B VRAY M LUTHY R
Citation: C. Carbon et al., THE ALPHA-TRIAL - EUROPEAN AUSTRALIAN RANDOMIZED DOUBLE-BLIND TRIAL OF 2 DOSES OF DIDANOSINE IN ZIDOVUDINE-INTOLERANT PATIENTS WITH SYMPTOMATIC HIV DISEASE/, AIDS, 10(8), 1996, pp. 867-880

Authors: VRAY M BOUVENOT G
Citation: M. Vray et G. Bouvenot, WE HAVE TO HAVE PRAGMATIC TRIALS, La Presse medicale, 24(22), 1995, pp. 1011-1012

Authors: VRAY M ATTALI JR
Citation: M. Vray et Jr. Attali, RANDOMIZED STUDY OF GLIBENCLAMIDE VERSUS TRADITIONAL CHINESE TREATMENT IN TYPE-2 DIABETIC-PATIENTS, Diabete et metabolisme, 21(6), 1995, pp. 433-439

Authors: VRAY M CHWALOW J CHARANSONNEY O VASMANT D CAPRON L BOCCALON H ESCHWEGE E
Citation: M. Vray et al., NATIONAL STUDY OF OBLITERATIVE ARTERIAL-DISEASE OF THE LOWER-LIMBS INVOLVING GENERAL-PRACTITIONERS IN FRANCE - ARTEMIO STUDY, Journal of cardiovascular pharmacology, 25, 1995, pp. 51-57

Authors: BOUVENOT G VRAY M
Citation: G. Bouvenot et M. Vray, IMPACT OF INTERNAL VALIDITY ON CLINICAL-T RIALS RESULTS, La Revue de medecine interne, 15(1), 1994, pp. 9-12

Authors: BALKAU B VRAY M ESCHWEGE E
Citation: B. Balkau et al., EPIDEMIOLOGY OF PERIPHERAL ARTERIAL-DISEASE, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000008-190000016

Authors: SELIGMANN M WARRELL DA ABOULKER JP CARBON C DARBYSHIRE JH DORMONT J ESCHWEGE E GIRLING DJ JAMES DR LEVY JP PETO TEA SCHWARZ D STONE AB WELLER IVD WITHNALL R GELMON K LAFON E SWART AM ABER VR BABIKER AG LHORO S NUNN AJ VRAY M
Citation: M. Seligmann et al., CONCORDE - MRC ANRS RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL OF IMMEDIATE AND DEFERRED ZIDOVUDINE IN SYMPTOM-FREE HIV-INFECTION/, Lancet, 343(8902), 1994, pp. 871-881

Authors: BOUVENOT G VRAY M
Citation: G. Bouvenot et M. Vray, CLINICAL-TRIALS - BEWARE OF BIAS, Revue du rhumatisme, 60(6), 1993, pp. 412-415
Risultati: 1-13 |